REKA

IL:CO:REKAH

Rekah Pharmaceutical Industries Ltd.

  • Stock

Last Close

1,431.00

21/11 15:24

Market Cap

181.26M

Beta: -

Volume Today

37

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
270.03M
-
216.37M
19.87%
262.43M
21.29%
218.38M
16.78%
208.18M
4.67%
207.83M
0.17%
196.50M
5.45%
265.47M
35.10%
263.95M
0.57%
292.39M
10.78%
321.66M
10.01%
cost of revenue
183.42M
-
151.01M
17.67%
181.13M
19.94%
150.62M
16.84%
140.08M
7.00%
141.09M
0.72%
135.38M
4.04%
196.83M
45.39%
198.79M
1.00%
213.69M
7.50%
241.46M
13.00%
gross profit
86.61M
-
65.36M
24.54%
81.30M
24.40%
67.76M
16.66%
68.10M
0.50%
66.74M
2.00%
61.12M
8.43%
68.64M
12.32%
65.16M
5.07%
78.70M
20.78%
80.20M
1.90%
selling and marketing expenses
11.96M
-
8.97M
25.00%
9.35M
4.27%
8.16M
12.72%
5.34M
34.62%
3.85M
27.95%
3.15M
17.99%
2.31M
26.85%
3.64M
57.78%
4.08M
11.98%
40.35M
889.94%
general and administrative expenses
6.15M
-
5.61M
8.82%
5.15M
8.19%
5.74M
11.58%
6.67M
16.25%
6.32M
5.29%
5.67M
10.27%
5.94M
4.78%
6.41M
7.77%
8.54M
33.31%
30.69M
259.39%
selling general and administrative expenses
18.11M
-
14.58M
19.51%
14.50M
0.52%
13.91M
4.10%
12.01M
13.61%
10.17M
15.36%
8.83M
13.19%
8.25M
6.53%
10.05M
21.75%
12.62M
25.58%
71.04M
463.11%
research and development expenses
1.50M
-
1.38M
8.07%
1.93M
40.28%
2.45M
26.90%
2.59M
5.42%
1.71M
33.95%
1.54M
9.72%
2.08M
35.02%
3.23M
55.24%
3.78M
16.89%
other expenses
61.75M
-
150K
99.76%
64K
57.33%
43.76M
68,278.13%
40.68M
7.04%
39.60M
2.65%
37.91M
4.27%
37.03M
2.34%
39.34M
6.25%
47.69M
21.21%
cost and expenses
263.27M
-
211.94M
19.50%
256.40M
20.97%
210.22M
18.01%
195.23M
7.13%
193.44M
0.91%
183.83M
4.97%
243.65M
32.54%
250.26M
2.71%
277.23M
10.78%
321.13M
15.84%
operating expenses
79.86M
-
60.93M
23.70%
75.27M
23.54%
59.60M
20.82%
55.15M
7.47%
52.36M
5.06%
48.45M
7.47%
46.82M
3.36%
51.47M
9.93%
63.54M
23.44%
79.67M
25.40%
interest expense
7.00M
-
7.22M
3.05%
6.27M
13.12%
5.55M
11.43%
4.76M
14.38%
4.31M
9.40%
5.10M
18.43%
5.81M
13.87%
5.63M
3.05%
5.65M
0.21%
ebitda
13.95M
-
13.64M
2.21%
14.36M
5.23%
17.70M
23.34%
22.95M
29.64%
25.13M
9.47%
27.10M
7.85%
40.01M
47.64%
36.39M
9.04%
40.24M
10.57%
26.03M
35.32%
operating income
18.12M
-
5.30M
70.75%
1.12M
78.91%
7.46M
567.62%
11.60M
55.36%
14.22M
22.64%
11.53M
18.92%
20.92M
81.45%
14.14M
32.39%
13.25M
6.30%
2.91M
78.07%
depreciation and amortization
6.83M
-
8.19M
19.99%
8.87M
8.25%
9.75M
9.90%
10.16M
4.27%
10.75M
5.82%
15.57M
44.78%
19.09M
22.60%
22.24M
16.55%
26.98M
21.30%
23.12M
14.32%
total other income expenses net
-6.67M
-
-5.90M
11.56%
-4.75M
19.35%
-17.37M
265.26%
-31.75M
82.82%
-4.30M
86.45%
-6.99M
62.38%
-6.76M
3.18%
-6.43M
4.88%
-12.90M
100.42%
-9.96M
22.80%
income before tax
11.46M
-
-595K
105.19%
-3.64M
511.26%
-9.90M
172.31%
-20.16M
103.52%
9.92M
149.20%
4.54M
54.19%
14.16M
211.60%
7.71M
45.54%
357K
95.37%
-7.05M
2,074.79%
income tax expense
3.07M
-
-154K
105.02%
715K
564.29%
1.10M
53.85%
2.44M
121.45%
3.07M
25.94%
1.79M
41.72%
3.36M
87.86%
1.10M
67.37%
2.40M
118.98%
138K
94.25%
net income
8.32M
-
-501K
106.02%
-4.41M
781.04%
-11M
149.21%
-22.48M
104.36%
7.03M
131.26%
2.75M
60.79%
10.80M
291.91%
6.62M
38.65%
-2.04M
130.84%
-6.91M
238.23%
weighted average shs out
5.46M
-
5.46M
0%
8.39M
53.60%
9.60M
14.37%
9.60M
0%
10.92M
13.73%
11.41M
4.56%
11.41M
0%
11.41M
0%
11.41M
0%
11.33M
0.76%
weighted average shs out dil
5.46M
-
5.46M
0%
8.39M
53.60%
9.60M
14.37%
9.60M
0%
10.92M
13.73%
11.41M
4.56%
11.41M
0%
11.41M
0%
11.41M
0%
11.41M
0%
eps
1.52
-
-0.09
106.03%
-0.53
477.97%
-1.15
116.98%
-2.34
103.48%
0.64
127.35%
0.24
62.50%
0.95
295.83%
0.58
38.95%
-0.18
131.03%
-0.61
238.89%
epsdiluted
1.52
-
-0.09
106.03%
-0.53
477.97%
-1.15
116.98%
-2.34
103.48%
0.64
127.35%
0.24
62.50%
0.95
295.83%
0.58
38.95%
-0.18
131.03%
-0.61
238.89%

All numbers in (except ratios and percentages)